Harmony Biosciences Holdings Inc
HRMY · NASDAQ
Harmony Biosciences Holdings, Inc. operates as a pharmaceutical company. The Company focuses on the research, drug development, and treatment for neurologic disorder of sleep-wake state instability. Harmony Biosciences Holdings serves patients in the United States.
Market Data
Price
$31.26
+0.21 (+0.68%)
Market Cap$1.80B
P/E Ratio11.32
EPS$—
52W High$40.87
52W Low$25.52
Beta0.98
Data from Finnhub · Updated May 1, 2026